This webcast features: Kristin O’Neill, Principle Scientist, and William Tran, Sr. Bioprocess Engineer, Merck & Co., Inc., and Kevin Mullen, Senior Product Manager, Thermo Fisher Scientific

As the demand for single-use technologies increases in terms of performance, efficiency, and ease-of-use, Thermo Fisher Scientific has introduced a next-generation bioreactor to the biopharma industry: The Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor (SUB).

Building on our extensive experience, as well as nearly two decades of end-user feedback, the HyPerforma DynaDrive SUB employs a new agitator-drive technology, with carefully engineered hardware enabling exceptional performance including:

These improvements enable use across the manufacturing landscape, from preclinical to commercial production. Additionally, the vast performance increases make it an ideal choice for both current and upcoming processes that may stretch the limits of biology and engineering in legacy single-use systems.

To highlight the capabilities of the HyPerforma DynaDrive SUB, Merck & Co. Inc., presents data on using a 50-L HyPerforma DynaDrive SUB in a high-demand perfusion process. Merck & Co., Inc., Kenilworth, NJ, USA, is known as MSD outside the United States and Canada. This presentation will show how cell densities >200 e06 cells/mL can easily be achieved at low gas flow-rate while also being tuned to allow sufficient control of pH and pCO2.

Coupled with ergonomic improvements, high performance without customization requirements, and the ability to integrate peripheral process analytical technology (PAT) into the controller and SUB, the HyPerforma DynaDrive SUB excels as a ready-made system for tomorrow’s processes.

Learning Objectives

Just fill out the form below to watch the recorded webcast.